Saxenda® is a clinically proven prescription weight management injection pen manufactured by Novo Nordisk, a pharmaceutical company from Denmark. It is approved by the U.S. FDA, the European Medicines Agency (EMA), and the Hong Kong Department of Health for weight management. 
Saxenda® belongs to the GLP-1 receptor agonist class of medicines. It mimics GLP-1, a naturally occurring gut hormone in the body, and may help support effective weight management. 
Looking for a more powerful option? 
Learn more about the latest Wegovy® or Mounjaro® (tirzepatide) treatment options, which may be suitable for people who require more intensive weight management support.

Saxenda® | GLP-1 Receptor Agonist | Liraglutide | Weight Loss Pen | 100% Authentic

Name: Saxenda® | GLP-1 Receptor Agonist | Liraglutide | Weight Loss Pen | 100% Authentic
SKU: FM-SAXEN-PEN-PARENT

HK$950.00

選擇盒數

Quantity

HK-65010
Who may be suitable for Saxenda®?

Saxenda® may be suitable for:

Adults with a BMI ≥ 30 kg/m²

Adults with a BMI ≥ 27 kg/m² to < 30 kg/m²

People with busy urban lifestyles who have limited time to exercise

People who tend to have a large appetite or often eat snacks and late-night meals

A doctor’s assessment is required before use to determine whether Saxenda® is suitable for your health condition.

Who may not be suitable for Saxenda®?

Saxenda® may not be suitable for people who:

Have had an allergic reaction to liraglutide or other GLP-1 receptor agonists

Have severe digestive system diseases

Are pregnant or breastfeeding

Have a history of severe acute pancreatitis

Have severe liver or kidney impairment or failure

Have Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Saxenda® is injected once daily and can be used at any time of the day. However, it is recommended to inject it at a consistent time each day. It is not affected by meal times.

Saxenda® is a subcutaneous injection. The recommended injection areas are the front of the abdomen, the outer thigh, or the upper arm.

Prepare the injection pen: Take out the injection pen, check that the solution is clear and free from particles, then attach a new needle.

Set the dose: Turn the dose selector to the dose instructed by your doctor.

Clean the injection site: Use an alcohol swab to clean the injection area.

Inject the medication: Insert the needle vertically into the skin and press the button until the indicator window shows that the injection is complete.

Hold for a few seconds: Keep the needle under the skin for around 6 seconds after injection to ensure the full dose has been delivered.

Dispose of the needle: Remove the used needle immediately after use and dispose of it properly in a sharps container.

The injection cycle and stopping time should be planned according to each individual’s health condition. The starting dose is 0.6 mg once daily, gradually increasing until reaching the maintenance dose of 3.0 mg once daily from week 5 onwards, as instructed by your doctor.

The recommended treatment period is at least one month, with 3 Saxenda® pens generally considered a complete treatment course.
Saxenda® may cause the following common side effects:

Nausea or vomiting

Diarrhoea or constipation

Dizziness or tiredness

Reduced appetite

Mild redness or swelling at the injection site

These symptoms usually appear at the beginning of treatment. As the body adjusts to the medication, most users may find that the symptoms gradually improve.

Rare but serious side effects may involve gallbladder disease or pancreatitis. Therefore, close monitoring is required during treatment, and medical advice should be sought promptly when needed.

If you experience any side effects, especially if the symptoms are severe or persistent, please consult your doctor.